<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Mon, 20 Apr 2026 14:17:07 -0400--><rss version="2.0">
    <channel>
        <title>Skye Bioscience, Inc. (SKYE) SEC Filings</title>
        <link>https://ir.skyebioscience.com/sec-filings/all-sec-filings/rss</link>
        <description>Skye Bioscience, Inc. (SKYE) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_e076ea37d6bf897725c32eff044cb88a/skyebioscience/files/theme/images/logo-sm.png</url>
                <title>Skye Bioscience, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025370/0001628280-26-025370.pdf</link>
                <pubDate>Thu, 16 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025370/0001628280-26-025370.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[DEFA14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025369/0001628280-26-025369.pdf</link>
                <pubDate>Thu, 16 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025369/0001628280-26-025369.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025368/0001628280-26-025368.pdf</link>
                <pubDate>Thu, 16 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-025368/0001628280-26-025368.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023937/0001628280-26-023937.pdf</link>
                <pubDate>Mon, 06 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023937/0001628280-26-023937.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[PREM14A - Preliminary proxy statements relating to merger or acquisition]]></title>
                <description><![CDATA[PREM14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023908/0001628280-26-023908.pdf</link>
                <pubDate>Mon, 06 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023908/0001628280-26-023908.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K/A - Current report]]></title>
                <description><![CDATA[8-K/A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023903/0001628280-26-023903.pdf</link>
                <pubDate>Mon, 06 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023903/0001628280-26-023903.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-10.1]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023699/0001628280-26-023699.pdf</link>
                <pubDate>Fri, 03 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023699/0001628280-26-023699.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023358/0001628280-26-023358.pdf</link>
                <pubDate>Thu, 02 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023358/0001628280-26-023358.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023356/0001628280-26-023356.pdf</link>
                <pubDate>Thu, 02 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023356/0001628280-26-023356.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023354/0001628280-26-023354.pdf</link>
                <pubDate>Thu, 02 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-023354/0001628280-26-023354.pdf</guid>
                                                                            </item>
            </channel>
</rss>